Fazamorexant - Shanghai Haiyan Pharmaceutical Technology
Alternative Names: HY-901139; YZJ-1139Latest Information Update: 29 May 2026
At a glance
- Originator Shanghai Haiyan Pharmaceutical Technology
- Class Amines; Aza compounds; Ethers; Fluorocarbons; Heterocyclic bicyclo compounds; Ketones; Pyridines; Pyrimidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Orexin receptor type 1 antagonists; Orexin receptor type 2 antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Insomnia